The usefulness of implementing minimum retest intervals in reducing inappropriate laboratory test requests in a Dutch hospital

Objectives: Inappropriate use of laboratory testing remains a challenging problem worldwide. Minimum retest intervals (MRI) are used to reduce inappropriate laboratory testing. However, their effectiveness and the usefulness in reducing inappropriate laboratory testing is still a matter of debate. The aim of this study was to evaluate the effectiveness of broadly implemented MRIs as a means of reducing inappropriate laboratory test requests. Methods: We performed a retrospective study in a general care and teaching hospital in the Netherlands, where MRI alerts have been implemented as standard care since June 7th 2017. Clinical chemistry test orders in adult internal medicine patients placed between July 13th 2017 and December 31st 2019 were included. The primary outcome was the effectiveness of MRIs, expressed as percentages of tests ordered and barred as a result of MRIs. Results: Of a total of 218,511 test requests, 4,159 (1.90%) got an MRI alert. These MRIs were overruled by physicians in 21.76% of the cases. As a result of implementing MRIs, 3,254 (1.49%) tests were barred. The financial savings for the department of internal medicine directly related to the included barred laboratory tests during this period were 11,880 euros on a total amount of 636,598 euros for all performed tests. Conclusions: Only a small proportion of laboratory tests are barred after implementation of MRIs, with a limited impact on the annual costs. However, MRIs provide a continuous reminder to focus on appropriate testing and the effectiveness of MRIs is potentially higher than described in this study.

Angaben zum Objekt

• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch

Verweise und Beziehungen

• Erschienen in: The usefulness of implementing minimum retest intervals in reducing inappropriate laboratory test requests in a Dutch hospital ; volume:61 ; number:3 ; year:2023 ; pages:412-418 ; extent:07 ; Clinical chemistry and laboratory medicine ; 61, Heft 3 (2023), 412-418 (gesamt 07)

Beteiligte, Orts- und Zeitangaben

• Urheber: Boerman, Anneroos W. ; Al-Dulaimy, Muhammad ; Bandt, Yvonne C. ; Nanayakkara, Prabath W.B. ; de Jonge, Robert

Weitere Informationen

• DOI: 10.1515/cclm-2022-0946
• URN: urn:nbn:de:101:1-2023012613062799286373
• Rechteinformation: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Letzte Aktualisierung: 15.08.2025, 07:36 MESZ